KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Aquestive Therapeutics (AQST) Preferred Dividend Payments (2017)

Aquestive Therapeutics has reported Preferred Dividend Payments over the past 1 years, most recently at $626000.0 for Q4 2017.

  • Quarterly results put Preferred Dividend Payments at $626000.0 for Q4 2017, changed N/A from a year ago — trailing twelve months through Dec 2018 was $626000.0 (changed N/A YoY), and the annual figure for FY2017 was $2.5 million, changed.
  • Preferred Dividend Payments for Q4 2017 was $626000.0 at Aquestive Therapeutics, roughly flat from $626000.0 in the prior quarter.
  • Over the last five years, Preferred Dividend Payments for AQST hit a ceiling of $626000.0 in Q3 2017 and a floor of $615000.0 in Q2 2017.